BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 21194809)

  • 21. Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones.
    Al-Omary FA; Abou-Zeid LA; Nagi MN; Habib el-SE; Abdel-Aziz AA; El-Azab AS; Abdel-Hamide SG; Al-Omar MA; Al-Obaid AM; El-Subbagh HI
    Bioorg Med Chem; 2010 Apr; 18(8):2849-63. PubMed ID: 20350811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
    Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
    Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.
    Rane RA; Sahu NU; Gutte SD; Mahajan AA; Shah CP; Bangalore P
    Eur J Med Chem; 2013 May; 63():793-9. PubMed ID: 23584542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents.
    Çalışkan B; Sinoplu E; İbiş K; Akhan Güzelcan E; Çetin Atalay R; Banoglu E
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1352-1361. PubMed ID: 30251900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological activity of new arenediyne-linked isoxazolidines.
    Romeo R; Navarra M; Giofrè SV; Carnovale C; Cirmi S; Lanza G; Chiacchio MA
    Bioorg Med Chem; 2014 Jul; 22(13):3379-85. PubMed ID: 24835789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biochemical evaluation of δ(2)-isoxazoline derivatives as DNA methyltransferase 1 inhibitors.
    Castellano S; Kuck D; Viviano M; Yoo J; López-Vallejo F; Conti P; Tamborini L; Pinto A; Medina-Franco JL; Sbardella G
    J Med Chem; 2011 Nov; 54(21):7663-77. PubMed ID: 21958292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
    Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
    Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiproliferative novel isoxazoles: modeling, virtual screening, synthesis, and bioactivity evaluation.
    Tzanetou E; Liekens S; Kasiotis KM; Melagraki G; Afantitis A; Fokialakis N; Haroutounian SA
    Eur J Med Chem; 2014 Jun; 81():139-49. PubMed ID: 24836066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of indole-containing 3,5-diarylisoxazoles as potential pro-apoptotic antitumour agents.
    Md Tohid SF; Ziedan NI; Stefanelli F; Fogli S; Westwell AD
    Eur J Med Chem; 2012 Oct; 56():263-70. PubMed ID: 22955095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
    Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo.
    Huang WY; Zhang XR; Lyu L; Wang SQ; Zhang XT
    Bioorg Chem; 2020 Jun; 99():103814. PubMed ID: 32278208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoxazoline containing natural products as anticancer agents: a review.
    Kaur K; Kumar V; Sharma AK; Gupta GK
    Eur J Med Chem; 2014 Apr; 77():121-33. PubMed ID: 24631731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines.
    Simoni D; Grisolia G; Giannini G; Roberti M; Rondanin R; Piccagli L; Baruchello R; Rossi M; Romagnoli R; Invidiata FP; Grimaudo S; Jung MK; Hamel E; Gebbia N; Crosta L; Abbadessa V; Di Cristina A; Dusonchet L; Meli M; Tolomeo M
    J Med Chem; 2005 Feb; 48(3):723-36. PubMed ID: 15689156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds.
    Mohamed MA; Ayyad RR; Shawer TZ; Abdel-Aziz AA; El-Azab AS
    Eur J Med Chem; 2016 Apr; 112():106-113. PubMed ID: 26890117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, molecular modelling and biological evaluation of 4-amino-2(1H)-quinazolinone and 2,4(1H,3H)-quinazolidone derivatives as antitumor agents.
    Richter S; Gioffreda B
    Arch Pharm (Weinheim); 2011 Dec; 344(12):810-20. PubMed ID: 21987492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lignopurines: a new family of hybrids between cyclolignans and purines. Synthesis and biological evaluation.
    Castro MÁ; Miguel del Corral JM; García PA; Rojo MV; Bento AC; Mollinedo F; Francesch AM; San Feliciano A
    Eur J Med Chem; 2012 Dec; 58():377-89. PubMed ID: 23153810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure.
    Dohle W; Jourdan FL; Menchon G; Prota AE; Foster PA; Mannion P; Hamel E; Thomas MP; Kasprzyk PG; Ferrandis E; Steinmetz MO; Leese MP; Potter BVL
    J Med Chem; 2018 Feb; 61(3):1031-1044. PubMed ID: 29227648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and anticancer activity of novel spiro-isoxazoline and spiro-isoxazolidine derivatives of α-santonin.
    Khazir J; Singh PP; Reddy DM; Hyder I; Shafi S; Sawant SD; Chashoo G; Mahajan A; Alam MS; Saxena AK; Arvinda S; Gupta BD; Kumar HM
    Eur J Med Chem; 2013 May; 63():279-89. PubMed ID: 23501113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of quinazolin-4(3H)-one derivatives bearing dithiocarbamate side chain at C2-position as potential antitumor agents.
    Ding PP; Gao M; Mao BB; Cao SL; Liu CH; Yang CR; Li ZF; Liao J; Zhao H; Li Z; Li J; Wang H; Xu X
    Eur J Med Chem; 2016 Jan; 108():364-373. PubMed ID: 26703795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploration of the SAR of anti-invasive chalcones: synthesis and biological evaluation of conformationally restricted analogues.
    Roman BI; Ryck TD; Dierickx L; Vanhoecke BW; Katritzky AR; Bracke M; Stevens CV
    Bioorg Med Chem; 2012 Aug; 20(15):4812-9. PubMed ID: 22743088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.